Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.

McCreary EK, Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01245-19. doi: 10.1128/AAC.01245-19. Print 2019 Oct.

PMID:
31332058
2.

Redox-Active Bis(phenolate) N-Heterocyclic Carbene [OCO] Pincer Ligands Support Cobalt Electron Transfer Series Spanning Four Oxidation States.

Harris CF, Bayless MB, van Leest NP, Bruch QJ, Livesay BN, Bacsa J, Hardcastle KI, Shores MP, de Bruin B, Soper JD.

Inorg Chem. 2017 Oct 16;56(20):12421-12435. doi: 10.1021/acs.inorgchem.7b01906. Epub 2017 Oct 2.

PMID:
28968088
3.

Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.

Bharucha AE, Batey-Schaefer B, Cleary PA, Murray JA, Cowie C, Lorenzi G, Driscoll M, Harth J, Larkin M, Christofi M, Bayless M, Wimmergren N, Herman W, Whitehouse F, Jones K, Kruger D, Martin C, Ziegler G, Zinsmeister AR, Nathan DM; Diabetes Control and Complications Trial–Epidemiology of Diabetes Interventions and Complications Research Group.

Gastroenterology. 2015 Aug;149(2):330-9. doi: 10.1053/j.gastro.2015.05.007. Epub 2015 May 14.

4.

Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.

McGee P, Steffes M, Nowicki M, Bayless M, Gubitosi-Klug R, Cleary P, Lachin J, Palmer J; DCCT/EDIC Research Group.

Diabet Med. 2014 Oct;31(10):1264-8. doi: 10.1111/dme.12504. Epub 2014 Jun 9.

5.

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.

Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B; DCCT/EDIC Research Group.

Diabetes. 2013 Dec;62(12):3976-86. doi: 10.2337/db13-1093. No abstract available.

6.

Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.

Genuth SM, Backlund JY, Bayless M, Bluemke DA, Cleary PA, Crandall J, Lachin JM, Lima JA, Miao C, Turkbey EB; DCCT/EDIC Research Group.

Diabetes. 2013 Oct;62(10):3561-9. doi: 10.2337/db12-0546. Epub 2013 Mar 21.

7.

Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus.

Kramer JR, Bayless ML, Lorenzi GM, Ziegler GK, Larkin ME, Lackaye ME, Harth J, Diminick LJ, Anderson KL, Braffett BH, Cleary PA; DCCT/EDIC Study Group.

Clin Trials. 2012 Dec;9(6):798-805. doi: 10.1177/1740774512458986. Epub 2012 Oct 1.

8.

Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).

Larkin ME, Lorenzi GM, Bayless M, Cleary PA, Barnie A, Golden E, Hitt S, Genuth S.

Clin Trials. 2012 Aug;9(4):418-25. doi: 10.1177/1740774512449532. Epub 2012 Jun 22.

9.

A CTSA-sponsored program for clinical research coordination: networking, education, and mentoring.

Brandt DS, Bosch M, Bayless M, Sinkey CA, Bodeker K, Sprenger K, Johnson K, Gilmore JM.

Clin Transl Sci. 2011 Feb;4(1):42-7. doi: 10.1111/j.1752-8062.2011.00259.x.

10.

Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes.

Mehra R, Raman R, Bayless ML, Sivitz WI.

J Diabetes. 2009 Dec;1(4):273-7. doi: 10.1111/j.1753-0407.2009.00044.x.

11.

Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.

Larkin ME, Backlund JY, Cleary P, Bayless M, Schaefer B, Canady J, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Diabet Med. 2010 Apr;27(4):451-8. doi: 10.1111/j.1464-5491.2010.02972.x.

PMID:
20536518
12.

The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort.

Jacobson AM, Paterson AD, Ryan CM, Cleary PA, Waberski BH, Weinger K, Musen G, Dahms W, Bayless M, Silvers N, Harth J, Boright AP; DCCT/EDIC Research Group.

Diabet Med. 2010 Jan;27(1):15-22. doi: 10.1111/j.1464-5491.2009.02885.x.

13.

Glycemic control and hypoglycemia: is the loser the winner? Response to Perlmuter et al.

Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2009 Apr;32(4):e46; discussion e47. doi: 10.2337/dc08-2264. No abstract available.

14.

Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial.

Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2008 Oct;31(10):1933-8. doi: 10.2337/dc08-0607. Epub 2008 Jul 7.

15.

Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.

Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG.

J Diabetes Complications. 2007 May-Jun;21(3):149-57.

PMID:
17493547
16.

Long-term effect of diabetes and its treatment on cognitive function.

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J.

N Engl J Med. 2007 May 3;356(18):1842-52. Erratum in: N Engl J Med. 2009 Nov 5;361(19):1914.

17.

Probing protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements.

Kaufman ED, Belyea J, Johnson MC, Nicholson ZM, Ricks JL, Shah PK, Bayless M, Pettersson T, Feldotö Z, Blomberg E, Claesson P, Franzen S.

Langmuir. 2007 May 22;23(11):6053-62. Epub 2007 Apr 28.

PMID:
17465581
18.

Leptin and body fat in type 2 diabetes and monodrug therapy.

Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, Haynes WG.

J Clin Endocrinol Metab. 2003 Apr;88(4):1543-53.

PMID:
12679437
19.

Stress and metabolic control in diabetes mellitus: methodological issues and an illustrative analysis.

Kramer JR, Ledolter J, Manos GN, Bayless ML.

Ann Behav Med. 2000 Winter;22(1):17-28. Review.

PMID:
10892525
20.

Leasing strategies reduce the cost of financing healthcare equipment.

Bayless ME, Diltz JD.

Healthc Financ Manage. 1985 Oct;39(10):38-48.

PMID:
10273774

Supplemental Content

Loading ...
Support Center